These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9381386)

  • 21. Treatment of patients with secondary Raynaud's syndrome.
    Ehrly AM
    Acta Chir Scand Suppl; 1976; 465():92-5. PubMed ID: 1069443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Raynaud's phenomenon].
    Levy Y; Shoenfeld Y
    Harefuah; 1993 Mar; 124(5):288-91. PubMed ID: 8098699
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al.
    Lichtenstein JR
    Arthritis Rheum; 2003 Jan; 48(1):282-3; author reply 283. PubMed ID: 12528146
    [No Abstract]   [Full Text] [Related]  

  • 24. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raynaud's (primary).
    Pope J
    Clin Evid; 2003 Dec; (10):1444-53. PubMed ID: 15555156
    [No Abstract]   [Full Text] [Related]  

  • 26. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2005 Jun; (13):1546-54. PubMed ID: 16135302
    [No Abstract]   [Full Text] [Related]  

  • 27. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2004 Dec; (12):1725-34. PubMed ID: 15865744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Raynaud's syndrome].
    Mishima Y
    Ryumachi; 1983 Oct; 23(5):370-5. PubMed ID: 6369565
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon?
    Tagliarino H; Purdon M; Jamieson B; Hoekzema G
    J Fam Pract; 2005 Jun; 54(6):553-5. PubMed ID: 15939010
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spasm and Raynaud's phenomenon].
    Fiessinger JN
    Ann Cardiol Angeiol (Paris); 1981; 30(2):91-3. PubMed ID: 7259052
    [No Abstract]   [Full Text] [Related]  

  • 32. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.
    Kumar N; Griffiths B; Allen J
    J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 34. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2003 Jun; (9):1339-48. PubMed ID: 12967424
    [No Abstract]   [Full Text] [Related]  

  • 35. Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome.
    Levy Y; Sherer Y; Shoenfeld Y
    Isr Med Assoc J; 2000 Dec; 2(12):960-1. PubMed ID: 11344792
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and management of scleroderma peripheral vascular disease.
    Herrick A
    Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasodilator refractoriness in Raynaud's syndrome.
    Sarkany I; Tan OT; Gaylarde PM
    Clin Exp Dermatol; 1982 Nov; 7(6):679-80. PubMed ID: 7151321
    [No Abstract]   [Full Text] [Related]  

  • 38. Joint hypermobility syndrome and bilateral total occlusion of the ulnar arteries presenting as Raynaud's phenomenon.
    Haberhauer G; Feyertag J; Hanusch-Enserer U; Dunky A
    Clin Exp Rheumatol; 2000; 18(2):270-1. PubMed ID: 10812513
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of Raynaud's phenomenon].
    Boccalon H; Monin A; Reggy M
    Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dihydroergocristine in the treatment of Raynaud's disease].
    Castelli PM; Sironi G
    Minerva Cardioangiol; 1977 Sep; 25(9):757-63. PubMed ID: 413069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.